Premier Biomedical, Inc.
BIEI · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $714 | $989 | $4,835 | $3,400 |
| - Cash | $0 | $4 | $0 | $0 |
| + Debt | $608 | $568 | $437 | $436 |
| Enterprise Value | $1,322 | $1,553 | $5,272 | $3,836 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$57 | -$3 | -$17 | -$5 |
| % Margin | – | – | – | – |
| Net Income | -$99 | -$202 | -$49 | -$39 |
| % Margin | – | – | – | – |
| EPS Diluted | -0 | -0 | 0 | 0 |
| % Growth | 50% | – | – | – |
| Operating Cash Flow | – | -$171 | $3 | -$5 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | -$171 | $3 | -$5 |